Dexmedetomidine premedication in cataract surgery under topical anaesthesia: to assess patient and surgeon satisfaction by Ghogki, PS et al.
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojaa 17
South Afr J Anaesth Analg
ISSN 2220-1181           EISSN 2220-1173 
© 2015  The Author(s)
RESEARCH
Southern African Journal of Anaesthesia and Analgesia 2015; 21(2):17-21
http://dx.doi.org/10.1080/22201181.2015.1028225
Open Access article distributed under the terms of the 
Creative Commons License [CC BY-NC-ND 4.0] 
http://creativecommons.org/licenses/by-nc-nd/4.0
South fr J naesth nalg
ISSN 2220-1181 EISSN 2220-1173
© 2015 The Author(s)
uthern African Journal of Anaesthesia nd Analgesia  015; 21(2):1–5
ttp: /dx.d i.org/ 0.1080/22201181.2015.1028225 
en Access article distrib ted under the terms of the
reative Co mons License [CC BY-NC-ND 4.0]
ttp: /creativecomm ns.org/licenses/by-nc-nd/4.0
Southern African Journal of Anaesthesia and Analgesia is co-published by Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor & Francis Group
Dexmedetomidine premedication in cataract surgery under topical anaesthesia: 
to assess patient and surgeon satisfaction
Poonam S Ghodkia*, Shalini P Sardesaia and Swapnagandha S Halikarb
a  Department of Anaesthesiology, Shrimati Kashibai Navale Medical College, Pune, India
b  Department of Ophthalmology, Shrimati Kashibai Navale Medical College, Pune, India
*Corresponding author, email: drpoonamghodki@gmail.com
Background: Dexmedetomidine is a potent non-opioid analgesic that may enhance analgesia for cataract surgery under topical 
anaesthesia. This study was undertaken to assess sedation and analgesia provided by dexmedetomidine and evaluating patients’ 
Methods: We conducted a prospective randomized study on ASA I/II patients presenting for cataract surgery under topical an-
esthesia. Patients were randomly assigned to two groups: group D received dexmedetomidine premedication 1 mcg/kg over 
10 minutes and group C received saline at the same rate. Sedation and pain score, intraocular pressure, patient and surgeon 




D had better patient and surgeon satisfaction score as against group C (p
higher in group D. Hemodynamic parameters were well maintained in both groups with no adverse events in either group. 
Conclusions: Dexmedetomidine can be used safely for cataract surgery under topical anesthesia surgery. Administration of dex-
medetomidine was associated with better patient and surgeon satisfaction.
Keywords: cataract surgery, dexmedetomidine, intraocular pressure, patient and surgeon satisfaction, topical anesthesia
Introduction
Traditionally, cataract surgeries are performed under regional 
anaesthesia with either a peribulbar or retrobulbar block. With the 
anaesthesia has also evolved from painful regional blocks to painless 
topical anaesthesia.1 However, with topical anaesthesia the patient 
has to cooperate for an akinetic eye as compared with a regional 
block. The requirement for cooperation may lead to increased 
anxiety in patients. Moreover, the fall in intraocular pressure (IOP) 
seen with regional block, which is desirable for a good operative 
is preferred as the patient is not required to undergo the painful 
injections for blocks and avoids the complications of blocks, 
including globe perforation and optic nerve injury.1,2 Nevertheless, 
all cataract surgeries whether under regional blocks or topical 
anesthesia are performed under monitored anesthesia care (MAC) 
requiring the presence of an anaesthetist.3
Several agents such as propofol, midazolam and opioids have 
been used to allay anxiety and provide sedation for cataract 
surgery.4–6 However, each of these drugs has limitations including 
over-sedation leading to impairment of patient’s cooperation 
and respiratory depression. Dexmedetomidine is an alpha2 
agonist that provides sedation and analgesia without respiratory 
depression.7,8 Dexmedetomidine, through its central action, has 
been shown to decrease IOP.9
Previous studies on dexmedetomidine have been conducted 
either in cataract surgeries under regional blocks or have not 
included IOP in the studied parameter.10,11 The aim of our study 
on patient’s satisfaction by assessing sedation and pain scores as 
well as surgeon’s satisfaction by assessing the operating 
under topical anaesthesia.
Material and methods
After institutional ethics committee approval, the study was 
conducted on 60 patients as a placebo controlled, randomized 
double blind study. Patients were fully informed about the 
study protocol and provided written informed consent. 
cataract surgery under topical anaesthesia. Exclusion criteria 
were any contraindication to the use of dexmedetomidine 
(cardiac disorders, hypertensive patients on beta blockers, liver 
and kidney diseases). Using a computer generated 
randomisation schedule, patients were assigned to either of 
the following two groups:
•  Group D: Received dexmedetomidine premedication 
(n = 30)
•  Group C: Received saline (n
During the preanaesthesia check-up, numeric rating scale (NRS) 
3 On arrival in the operating 
theatre, basic monitors were attached and the baseline values of 
heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), 
oxygen saturation (spO2), end tidal carbon dioxide using a side 
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Group D received intravenous infusion of dexmedetomidine 
the same rate. The infusion was started by anesthesiologist who 
was delivered to all patients using a nasal cannula. Intraoperative 
sedation was monitored using Ramsay sedation score (RSS)12 
target end point was reached before completing the infusion, the 
infusion was stopped and noted. All the parameters to be studied 
i.e. HR, MAP, spO2, RR, etCO2, NRS (pain and patient satisfaction) 
and RSS were monitored and recorded for each patient before 
premedication (T1), after premedication (T2), intra operatively 
(T3) and post operatively (T4). The ophthalmologist, blinded to 
the study group, measured the IOP using a Schioetz tonometer 
under topical analgesia in the non-operated eye. The IOP was 
recorded before the premedication and at the end of the surgery. 
Surgery was performed under topical anaesthesia using 
instillation of few drops of 0.5% paracaine.
values below 20% of baseline) was recorded and treated with 
intravenous atropine or ephedrine respectively. All adverse 
events including but not limited to respiratory depression, 
nausea, vomiting, dry mouth and oversedation were also noted. 
fentanyl 1 mcg/kg. The number of patients who needed fentanyl 
was recorded.
At the end of surgery, patients were asked about average level of 
pain and the surgeon satisfaction was assessed by the adequacy 
of operating conditions using the following scale: excellent 
(completely calm and cooperative patient), good (cooperative 
patient but slight undesirable movements of eyes) and poor 
(highly uncooperative patient with severe undesirable 
movements of eyes).3 Patients were monitored in the recovery 
room, their Aldrete score observed and then discharged to the 
ward. All the study data was recorded by a blinded observer.
Based upon previously published data,10,11 we assumed that the 
whereas with dexmedetomidine, sedation would be obvious in at 
least 40% of patients and this provided an 80% power with an 
error equal to 0.05, therefore a sample size of 22 patients per 
cases with violation of study protocol, a total of 30 cases were 
studied in each group.
Statistical analysis was conducted with SPSS (version 10) for 
Windows statistical package using paired and unpaired Student’s 
t-test. Parametric variables such as age, duration of surgery, HR, 
MAP, spO2, RR, etCO2 and IOP were analysed using a t-test, while 
for non-parametric data (NRS and RSS), Mann–Whitney test was 
employed. A p
Results
The groups were comparable in terms of demographic data, ASA 
grading and duration of surgery (Table 1).
The mean dexmedetomidine dose in group D was 65.4(3.6) mcg 
(1.08 mcg/kg)
The baseline values of HR and MAP were similar in both study 
groups. However, a gradual fall in both HR and MAP was recorded 
in group D after completion of infusion which continued 
throughout the intra and postoperative period (p). One patient in 
group D needed atropine for bradycardia, but the study drug was 
not stopped after atropine administration. There was a fall in MAP, 
but none of the patients needed ephedrine treatment. (Table 2)
Table 1:
Group D Group C p-value
Age (years) 62.6 (6.5) 61.4 (6.9) NS
Weight (kgs) 60.4 (10.2) 58.6 (11.2) NS
Male/Female 11:19 10:20 NS
ASA I/II 20:10 21:9 NS
Duration of surgery (minutes) 23.4 (4.4) 22.7 (5.2) NS
Note: Values expressed as Mean (SD). NS: p
Table 2: Heart rate (HR) and Mean arterial pressure (MAP) changes
T1 T2 T3 T4
HR (per min)
Group D 74.5(8.18) 72.42(13.25) 76.00(14.21) 68.50(11.54)
Group C 73.52(7.82) 81.4(7.36) 89.75(9.21) 79.50(15.68)
p-value 0.74 0.005 0.000 0.009
MAP (mm of Hg)
Group D 92.46(8.32) 86.88(10.75) 88.26(11.03) 81.02(11.10)
Group C 95.70(9.42) 99.10(12.36) 107.20(7.90) 90.03(9.24)
p-value 0.28 0.005 0.000 0.008
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The etCO2 monitored from the side stream capnometer, albeit a 
rough indication of ventilation, was maintained in both the groups 
(Figure 1). Despite an apparently normal etCO2 on monitor, any 
occurrence of hypoventilation could not be precisely ruled out.
All patients received oxygen by nasal prongs, the saturation was 
maintained and respiratory rate was never below 10/min in both 
the groups (Figures 2 and 3).
The preoperative IOP values were similar in both the groups. 
postoperatively as compared to group C (from mean 
3)
While comparing the sedation, we observed that the overall RSS 
was higher at all times after completion of premedication in group 
D (p 3, the 
patients had a lower RSS in group C.
The patients’ NRS for studying overall satisfaction was higher in 
improvement in patient’s satisfaction with dexmedetomidine 
premedication. In group D, a maximum score of 10 was given by 
patients, while in group C, the maximum score given was 8 (Table 3).
Neither the intraoperative (p
(p 3). 
However two patients in group C demanded rescue analgesia and 
were given fentanyl boluses. None of the patients in group D 
3)
In group D, the quality of operating conditions as assessed by 
ophthalmologist (surgeon satisfaction score) was rated excellent in 
26 patients and good in rest 4, while in group C, only 13 patients had 
excellent conditions and other 17 had good operating conditions. 
None of the patients exhibited poor operating conditions. This 
p 3)
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Figure 3: Changes in Respiratory rate (per min)
Table 3: Other parametric and nonparametric data
Group D Group C p-value
IOP (mm of Hg)
Baseline 17.10(1.92) 16.90(4.11) NS
End of surgery 13.81(1.63) 15.41(3.93) <0.0001
RSS (average score) 2.67(0.48) 1.56(0.44) <0.0001
VAS for pain (per op) 3(0–4) 3(2–4) 0.182
(post op) 1(0–1) 1(1–2) 0.081
Requirement of fentanyl (no. of patients) 0 2 –
Patient satisfaction score 9(8–10) 7(5–8) 0.0001
Surgeon satisfaction score (excellent/good) 26/4 13/17 0.0001
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aminobutyric system,7 contrary to the situation with the 
benzodiazepines.18,19
studies.10,11,18
Patients were more comfortable with better sedation scores in 
group D. This could be explained, at least in part, by the additional 
analgesic property of dexmedetomidine that improves patient’s 
perception of sedation.8,15 However, we could not demonstrate 
better pain scores in group D, as topical anesthesia itself provided 
adequate sensory anaesthesia.
Dexmedetomidine, by its central action leads to a fall in IOP.7,20 
sedated but cooperative patient would provide better operating 
conditions providing a reason for better surgeon satisfaction in 
group D. The reduced IOP found in this study is in agreement with 
the study results of Ayoglu et al.11
The single dose of dexmedetomidine, used in this study is not 
occurrence of dry mouth is an established fact with the use of 
alpha 2 agonists7 but did not reduce patient satisfaction.
There are limitations to this study. Firstly, only ASA status I and II 
status III/IV, further studies recruiting high-risk patients need to be 
carried out. A second limitation was in monitoring respiration – 
although saturation and respiratory rate were accurately 
monitored, we used a side stream capnometer to monitor etCO2, 
which requires airway instrumentation for accurate measurement 
and is inherently less accurate in sedated patients without airway 
capnometer has been used previously to measure etCO2 in sedated 
patients.10 Another possible limitation is the use of RSS to monitor 
sedation as opposed to the use of bispectral index or entropy. The 
RSS is more appropriate for sedated patients while monitoring 
depth of anaesthesia is more appropriate for general anaesthesia 
and monitors may not be readily available in all institutions.
Conclusion
We conclude that dexmedetomidine can be used safely for MAC 
in cataract surgery as the drug is associated with better patient 
and surgeon satisfaction. However, patients need to be closely 
monitored, following minimum monitoring standards.
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